# data[].attributes.body
Trisomy 13, also called Patau Syndrome, is a rare genetic disorder that happens when a baby is born with an extra copy of chromosome 13. This extra chromosome causes developmental problems that affect nearly every part of the body.

Babies with Trisomy 13 often have heart defects, brain differences, and facial abnormalities, including cleft lips or extra fingers and toes. Many also have difficulty breathing and feeding.

This condition is very rare, occurring in about 1 in 10,000 to 16,000 births. Most cases happen randomly during the formation of egg or sperm cells. Trisomy 13 affects males and females almost equally.

Doctors usually detect Trisomy 13 before birth through genetic testing, and babies born with this condition require a lot of medical care. Because of the serious health problems caused by the extra chromosome, most babies with Trisomy 13 do not survive past infancy.

Babies with this condition often have extra fingers or toes, a condition called polydactyly. Many babies are born with a cleft lip or palate, which can make feeding difficult. Doctors have also discovered that Trisomy 13 is more likely to occur when the mother is older, although it can happen at any age.

Researchers continue to study why this condition happens, but because it a random mutation and not one inherited through generations, it remains unpredictable. Some scientists are also working on ways to improve medical care for babies born with Trisomy 13 to help them live longer.

# data[].attributes.body
Trisomy 18, also known as Edwards Syndrome, is a rare genetic condition caused by an extra copy of chromosome 18. This extra chromosome affects development and leads to problems such as heart defects, organ abnormalities, and slow growth.

Babies with Trisomy 18 are often very small, have clenched fists with overlapping fingers, and may have difficulty breathing and feeding.

Trisomy 18 occurs in about 1 in 5,000 births and affects more girls than boys. Most cases happen randomly when egg or sperm cells form.

Because of the many medical complications, most babies with Trisomy 18 do not survive past their first year. However, doctors and researchers continue to study this condition to improve treatments and support for affected families.

A surprising fact about Trisomy 18 is that more females (XX) are affected than males (XY). Scientists are not exactly sure why, but males with the condition tend to survive for even shorter periods than females. Babies with Trisomy 18 often have a small head and jaw, which can make breathing and eating very difficult. Since the condition is caused by an extra chromosome that forms randomly, most cases are not inherited. Researchers are studying how the extra chromosome affects different organs and why it causes such severe complications. While there is no cure, doctors are working on ways to provide better supportive care for affected infants.

# data[].attributes.body
Trisomy 21, or Down Syndrome, is a genetic disorder caused by having an extra copy of chromosome 21. This extra chromosome affects how a person develops, leading to unique facial features, learning differences, and sometimes health problems like heart defects or hearing loss. However, people with Down Syndrome can live full, happy lives with the right medical care, education, and support.

Down Syndrome is the most common chromosomal disorder, occurring in about 1 in 700 babies in the United States. It can happen to anyone, but it is more likely when the mother is older. Down Syndrome occurs in both males and females at nearly the same rate.

Doctors can detect Down Syndrome before birth through special tests. People with Down Syndrome may take longer to learn certain skills, but with therapies and support, they can go to school, play sports, work, and live independently as adults.

The condition was first described by Dr. John Langdon Down in 1866. Today, there are many resources and programs that help people with Down Syndrome thrive and reach their full potential.

One of the most well-known facts about Down Syndrome is that people with the condition often have a friendly and social personality. Many individuals with Down Syndrome live long, fulfilling lives and participate in school, sports, and work. The life expectancy for people with Down Syndrome has improved dramatically in recent years, increasing from about 25 years in 1983 to over 60 years today. Scientists have also been studying ways to improve learning and memory in individuals with Down Syndrome, including potential medications that could enhance brain function. While there is no cure, advances in therapy and education have helped people with Down Syndrome now more than ever.

# data[].attributes.body
Huntington’s Disease is a genetic disorder that affects the brain, causing problems with movement, thinking, and emotions. It is caused by a mutation in a gene on chromosome 4, which leads to the gradual breakdown of nerve cells in the brain. Huntington’s disease affects approximately 1 in 10,000 to 1 in 20,000 people in the United States. Huntington’s Disease affects males and females equally.

People with Huntington’s Disease may have trouble walking, speaking, remembering things, and controlling their emotions. Symptoms usually start between the ages of 30 and 50 and get worse over time.

Unlike Trisomy conditions, Huntington’s Disease is directly inherited from parents. If one parent has the gene mutation, their child has a 50% chance of getting the disease. Scientists have discovered that the more times a certain DNA sequence repeats in the gene, the earlier and more severe the symptoms become.

There is no cure for Huntington’s Disease, but treatments can help manage symptoms. Doctors and researchers are working to find new ways to slow down or stop the disease from progressing. The condition was first described by Dr. George Huntington in 1872, and since then, scientists have learned a lot about how it works.

One of the most interesting discoveries about Huntington’s Disease is that the severity of the disease depends on how many times a specific DNA sequence repeats in the mutated gene. The more repeats a person has, the earlier symptoms begin. This disease is inherited in a dominant pattern, meaning if a person has just one copy of the faulty gene, they will eventually develop symptoms. Unlike many other genetic disorders, symptoms usually do not appear until adulthood, making genetic testing an important tool for families who may be at risk. Scientists are currently working on gene therapy approaches that might slow down or even stop the progression of the disease. A few experimental treatments are already being tested in clinical trials, giving hope to families affected by Huntington’s.

# data[].attributes.body
Cystic Fibrosis (or CF) is a genetic disorder that affects the lungs and digestive system. It happens when a person inherits two faulty copies (one from each parent) of the CFTR gene on chromosome 7. This gene mutation causes the body to produce thick, sticky mucus that clogs the lungs and makes it hard to breathe. The mucus also affects the pancreas, making it difficult to digest food properly and absorb nutrients.

The birth frequency in the U.S. is about 1 in 3,500 births. It is most common among Caucasians of European descent, with about 1 in 25 people being a carrier of the CFTR gene mutation. Cystic Fibrosis occurs in both males and females at equal rates.

People with CF often have chronic coughing, lung infections, and trouble gaining weight. To manage the disease, they need daily treatments such as chest therapy to loosen mucus, medications, and special high-calorie diets. CF is most common in people of European descent, and about 30,000 people in the U.S. have the condition.

Although there is no cure for CF, scientists have developed new treatments that help people with the disease live longer, healthier lives. Some of these treatments target the defective gene itself, improving how the body handles mucus and other fluids. Doctors first identified CF in 1938, and since then, research has led to major advancements in care.

People with CF have saltier sweat than normal, which is caused by the defective CFTR gene. Today, doctors use genetic testing and sweat tests to diagnose the condition. Scientists have made incredible progress in CF research, including the development of new medications that target the faulty gene itself. Some of these drugs have greatly improved lung function and life expectancy for people with CF. Researchers are also working on gene editing techniques like CRISPR to correct the mutation that causes CF, which could one day lead to a cure.

# data[].attributes.body
Sickle Cell Anemia is a blood disorder caused by a mutation in the hemoglobin gene on chromosome 11. Sickle cell anemia occurs in approximately 1 in 2,500 births in the U.S. overall. Sickle Cell Anemia affects males and females equally. This mutation makes red blood cells change from their normal round shape to a crescent or "sickle" shape. These sickle cells don’t move through blood vessels as easily as normal cells, which can cause painful blockages, organ damage, and a lack of oxygen in the body. People with this condition often experience episodes of severe pain called "sickle cell crises," as well as fatigue and an increased risk of infections.

Sickle Cell Anemia is most common in people of African, Mediterranean, Middle Eastern, and Indian descent. It is inherited when a person receives two copies of the sickle cell gene —one from each parent. If someone inherits only one copy, they are a carrier and usually don’t have symptoms, but they can pass the gene on to their children. Interestingly, having one sickle cell gene helps protect against malaria, which is why the condition is more common in areas where malaria is common.

Doctors manage sickle cell disease with medications, blood transfusions, and sometimes bone marrow transplants. Although the condition was first identified in the early 1900s, research is still ongoing to find better treatments and possibly a cure.

One of the most unique things about Sickle Cell Anemia is that having just one copy of the sickle cell gene (instead of two) actually helps protect people from malaria. This is why the condition is more common in regions where malaria is widespread, such as Africa and parts of the Middle East. Unfortunately, people who inherit two copies of the gene experience painful sickle cell symptoms because their sickle-shaped blood cells block blood flow. Doctors have been using bone marrow transplants to cure some patients with Sickle Cell Anemia, but this treatment is not widely available. Newer research is focusing on gene therapy, which may one day provide a permanent cure by fixing the faulty gene before symptoms even start.